We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Landmark Year for Generics Cues Big Changes, Rulings in 2013
Landmark Year for Generics Cues Big Changes, Rulings in 2013
January 2, 2013
With the passage of milestone legislation implementing new user fee programs for generic drugs and biosimilars, along with the Supreme Court’s decision to take up the legality of reverse patent settlements and the scope of generic preemption, 2012 was a big year for the generic-drug industry.